Dr Reddys Laboratories Ltd Share Price Today - Live Blog for May 11, 2026

With a -1.19% decrease, Dr Reddys Laboratories Ltd's share price is now 1278.50. Investors should examine the factors driving this decline. The stock's PE ratio is 19.5400, whereas the industry PE ratio stands at 34.2661.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.24%, reaching a current market price of 1290.80. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

With a -0.24% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1290.80. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.5400, while the industry PE is 34.2661.

Dr Reddys Laboratories Ltd stock price decreased by -0.04%, with the current market value at 1293.40 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd witnessed a -0.04% drop in its share price and is currently trading at 1293.40. With the stock's PE at 19.5400 and the industry PE at 34.2661, investors are weighing their options.

Dr Reddys Laboratories Ltd share price has declined by -0.05%, and it's currently trading at 1293.20. The stock maintains a PE of 19.5400, while the industry PE is 34.2661, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd witnessed a -0.05% decrease in its share price, and it is currently trading at 1293.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price has declined by -0.52%, and it's currently trading at 1287.20. The stock maintains a PE of 19.5400, while the industry PE is 34.2661, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd shares saw a -0.52% decrease, reaching a current market price of 1287.20. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

After a -1.11% decline, Dr Reddys Laboratories Ltd shares are now trading at 1279.50. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -1.11% decrease in its share price, and it is currently trading at 1279.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.